Drop-outs in tamoxifen prevention trials [10]

Lancet

Volumn 353, Issue 9148, 1999, Pages 244-

  Veronesi, U ^a   Maisonneuve, P ^a   Costa, A ^a   Rotmensz, N ^a   Boyle, P ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CHEMOPROPHYLAXIS; FEMALE; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0032983355     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77261-5     Document Type: Letter

References (5)

1. KI Pritchard Is tamoxifen effective in prevention of breast cancer? Lancet 352 1998 80 81
2. U Veronesi P Maisonneuve A Costa Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women Lancet 352 1998 93 97
3. B Fisher JP Costantino DL Wickerham Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Projects P-1 study JNCI 90 1998 1371 1388
4. T Powels R Eeles S Ashley Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital Tamoxifen randomised chemoprevention trial Lancet 352 1998 98 101
5. Rotmensz N, Robertson C, Maisonneuve P, Boyle P. The effect of external events on a large double blind chemoprevention trial. 19th Annual Meeting of the Society for Clinical Trials, Atlanta May, 1998: 76 (abstr 71).